TCC Signs Lease for Regenerative Therapeutics Company at Fulton Labs in Chicago
Dimension Inx Will Occupy a 6,410-SF Science-Ready Lab Suite at 1375 West Fulton
February 15, 2023
Trammell Crow Company (TCC), a global commercial real estate developer, signed a lease with Dimension Inx, a biomaterials platform company that develops therapeutic products to restore tissue and organ function, at Fulton Labs in Chicago. The company will occupy a 6,410-square-foot Science-Ready Lab Suite at 1375 West Fulton, which is part of TCC’s two-building, 725,000-square-foot Fulton Labs Campus in Chicago’s Fulton Market neighborhood.
Dimension Inx currently operates out of two locations. Its primarily facility is based at Illinois Tech’s University Technology Park, and it also occupies space at the venture development engine Portal Innovations, located at 400 North Aberdeen, which is part of the Fulton Labs Campus. Dimension Inx will move into its new headquarters office and lab space in March 2023 and will still maintain a presence at Portal Innovations, given their ongoing strategic partnership.
“Dimension Inx expanding from Portal Innovations into its own facility, while remaining within our Fulton Labs Campus, is the perfect example of how our Science-Ready Lab Suites are a key component in the growth of Chicago’s life sciences ecosystem,” shared Morgan Baer Blaska of TCC’s Chicago office. “The Chicago life sciences cluster is growing significantly, as is the need for high-quality lab space. These suites were designed to fit the needs of growing companies, providing flexibility and minimal capital expenditures for both growth-stage startups and mature organizations looking to establish a presence in downtown Chicago. We look forward to welcoming Dimension to their new space and supporting their continued growth.”
“We’ve been bullish on our potential for growth in Chicago since we spun out of Northwestern University. Access to talent and world-class research institutions has been a mainstay in the region. With the addition of new, flexible lab space options and the growing fervor within the life sciences ecosystem, we remain incredibly excited about the opportunities here. We look forward to continuing our growth in tandem with the vibrant Chicago life sciences community”, said Dimension Inx CEO, Caralynn Nowinski Collens, M.D.
“The life sciences industry throughout Chicagoland is flourishing, and we couldn't be more excited to see companies like Dimension Inx seize the opportunity to grow and innovate within the dynamic environment of Fulton Labs and the broader region," stated Michael Fassnacht, President & CEO of World Business Chicago. "With access to state-of-the-art laboratory facilities and an exceptional infrastructure, Chicago provides an ideal ecosystem for companies to fast-track the development and commercialization of cutting-edge products. We look forward to Dimension Inx's continued success and growth.”
TCC unveiled its Science-Ready Lab Suites at Fulton Labs in 2022. The fully built out, move-in ready private labs span 3,000 to 7,000 square feet and provide advanced R&D laboratory space with world-class infrastructure that is optimized for various science use, including therapeutics, medical device, diagnostics, food science and materials research. Tenants have access to unparalleled building technology and amenities, including a shared lab equipment room, as well as flexible lease terms.
The Fulton Labs Campus is comprised of 1375 West Fulton, which includes 300,000 square feet and features the Science-Ready Lab Suites program, and 400 North Aberdeen, which spans 425,000 square feet and opened in Q1 2022. Other tenants include Celadyne Technologies, Portal Innovations, Charles River Laboratories, Xeris Pharmaceuticals, Vanqua Bio and Talis Biomedical.
Dimension Inx was represented by Jonathan Metzl and Jack Keenan of Cushman & Wakefield. CBRE handles the marketing and leasing for the project. For all campus leasing inquiries, contact Dan Lyne at [email protected].
Trammell Crow Company
Trammell Crow Company (TCC) is a global commercial real estate developer and wholly-owned subsidiary of CBRE Group, Inc. (NYSE:CBRE), a Fortune 500 and S&P 500 company headquartered in Dallas. Founded in 1948, TCC has developed or acquired nearly 2,900 buildings valued at $75 billion and over 655 million square feet. As of September 30, 2023, TCC had $15.4 billion of projects in process and $14.5 billion in its pipeline. It employs 650 professionals in 28 major cities throughout the United States and Europe. The company serves users of and investors in office, industrial/logistics, healthcare, life sciences and mixed-use projects, as well as multi-family residential through its operating subsidiary High Street Residential. For more information visit www.TrammellCrow.com.